Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Tff Pharmaceuticals Inc (NQ: TFFP )

0.3285 -0.0117 (-3.44%)
Streaming Delayed Price Updated: 1:37 PM EST, Nov 25, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Tff Pharmaceuticals Inc

< Previous 1 2 3 4 Next >
Stocks That Hit 52-Week Lows On Thursday
  Thursday saw 177 companies set new 52-week lows. 
Via Benzinga
Earnings Scheduled For August 11, 2022
Companies Reporting Before The Bell • Magic Software (NASDAQ:MGIC) is projected to report quarterly earnings at $0.27 per share on revenue of $131.70 million. 
Via Benzinga
Recap: TFF Pharmaceuticals Q1 Earnings
TFF Pharmaceuticals (NASDAQ:TFFP) reported its Q1 earnings results on Wednesday, May 11, 2022 at 04:00 PM. Here's what investors need to know about the announcement. 
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
On Wednesday, 807 companies reached new 52-week lows. 
Via Benzinga
The Daily Biotech Pulse: Veru Shares Up On COVID Candidate Update, FDA Approves Lilly's COVID Treatment, Latest On Sanofi-AstraZeneca RSV Vaccine
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
Earnings Scheduled For May 11, 2022
Companies Reporting Before The Bell • Great Elm Capital (NASDAQ:GECC) is expected to report earnings for its first quarter. 
Via Benzinga
The Daily Biotech Pulse: Thervance Gains On Positive Late-Stage Readout, Bristol-Myers Squibb Snags 3 Approvals In Europe, Decision Day For BioXcel
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
During Wednesday's trading, 435 companies set new 52-week lows. 
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
On Friday, 213 companies hit new 52-week lows. 
Via Benzinga
Looking Into TFF Pharmaceuticals's Return On Capital Employed
Benzinga Pro data, TFF Pharmaceuticals (NASDAQ:TFFP) reported Q4 sales of $12.00 thousand. Earnings fell to a loss of $10.05 million, resulting in a 15.8% decrease from last... 
Via Benzinga
The Daily Biotech Pulse: MEI Pharma Wilts On Adverse Regulatory Development, Decision Day For Zogenix, AN2 Therapeutics IPO
Here's a roundup of top developments in the biotech space over the last 24 hours. 
Via Benzinga
The Daily Biotech Pulse: Novartis Prostate Cancer Drug Lands FDA Approval, Ligand Announces SPAC Deal To Spin Off Antibody Business, Lilly's Lung Cancer Therapy Hit With CRL
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
Earnings Scheduled For March 24, 2022
Companies Reporting Before The Bell • iHuman (NYSE:IH) is likely to report earnings for its fourth quarter. • Pioneer Muni High Inc (NYSE:MAV) is expected to... 
Via Benzinga
Earnings Outlook For TFF Pharmaceuticals
TFF Pharmaceuticals (NASDAQ:TFFP) is set to give its latest quarterly earnings report on Thursday, 2022-03-24. Here's what investors need to know before the announcement. Analysts... 
Via Benzinga
The Week Ahead In Biotech (March 20-26): Focus On Zogenix FDA Decision, Dermatology Conference Presentations & Earnings
Biotech stocks rebounded along with the broader market in the week ending March 18, as risk appetite returned. Multiple conference presentations, clinical readouts and earnings news dictated sentiment... 
Via Benzinga
TFF Pharma Inks Research Pact With US Army For Dry Powder Medical Countermeasures
TFF Pharmaceuticals Inc (NASDAQ: TFFP) has entered into a Cooperative Research and Development Agreement (CRADA) with the U.S. 
Via Benzinga
TFF Pharma's Inhaled Niclosamide Shows Potent Activity Against Omicron Variant
Preclinical studies show that TFF Pharmaceuticals Inc's (NASDAQ: TFFP) inhaled niclosamide product candidate inhibits viral replication of both the Delta and... 
Via Benzinga
Recently Revealed Pfizer Collaboration Might Just Be What The Doctor Ordered For TFF Pharmaceuticals
By StoryTrading Pfizer collaboration just revealed in presentation update - no PR issued yet! – Several near-term catalysts possible, including further partnerships... 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Gainers BiondVax Pharmaceuticals (NASDAQ:BVXV... 
Via Benzinga
TFF Pharmaceuticals, Inc. (TFFP) Q3 2021 Earnings Call Transcript
TFFP earnings call for the period ending September 30, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers Entasis Therapeutics Hldg (NASDAQ:ETTX) shares moved upwards by 16.72% to $3.63 during Tuesday's pre-market session. The company's market cap stands at $... 
Via Benzinga
TFF Pharma's Inhaled Tacrolimus Powder Moves Closer To Phase 2 In Lung Transplantation
TFF Pharmaceuticals Inc (NASDAQ: TFFP) has announced topline results from Phase 1 trial for Tacrolimus Inhalation Powder. Data showed a good safety profile and... 
Via Benzinga
Earnings Scheduled For November 15, 2021
Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is estimated to report earnings for its third quarter. • Tyson Foods (NYSE:TSN) is estimated to... 
Via Benzinga
The Week Ahead In Biotech (Nov. 14-Nov. 20): BioMarin FDA Decision, Tapering Earnings News Flow, Conference Presentations And More
Biotech stocks declined for the second straight week amid a broader market pullback, along with earnings news from small- and micro-cap companies and presentations at... 
Via Benzinga
Exposures Product Safety
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers TransCode Therapeutics (NASDAQ:RNAZ) shares increased by 23.66% to $3.24 during Thursday's pre-market session. The company's market cap stands at $41.8... 
Via Benzinga
The Daily Biotech Pulse: NRx Stitches COVID-19 Drug Partnership, Protara Gets Nod For Starting Bladder Cancer Study, IGM Moves Beyond Oncology
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 11) AstraZeneca Plc (NASDAQ:... 
Via Benzinga
Exposures COVID-19
The Daily Biotech Pulse: Adcom Tryst For Pfizer/BioNTech Booster Shot, AbCellera's COVID Antibody Treatment Gets Expanded Use, Protagonist Slapped With Clinical Hold
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 16) Bicycle Therapeutics plc (... 
Via Benzinga
TFF Pharmaceuticals, Inc. (TFFP) Q2 2021 Earnings Call Transcript
TFFP earnings call for the period ending June 30, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Keynotes, Educational Panels and 60 Companies to Present at the SNN Network Summer Virtual Event on August 17-19, 2021
LOS ANGELES, CA / ACCESSWIRE / August 16, 2021 / The SNN Network Summer Virtual Event will take place on August 17-19, 2021, where 60 SmallCap, MicroCap and NanoCap public and private companies will be... 
From Stock News Now
Via AccessWire
Topics Cannabis
Exposures Cannabis
The Daily Biotech Pulse: Moderna's Vaccine Produces Durable Response Against Variants, FDA Approves Jazz's Sleep Disorder Drug, Dermata IPO
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 12) Adagio Therapeutics, Inc. (... 
Via Benzinga
Exposures Product Safety
< Previous 1 2 3 4 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.